DERMATOLOGY EDITION
Delgocitinib Cream for Chronic Hand Dermatitis: Efficacy, Safety and Clinical Application
Delgocitinib 2% cream is the first topical pan-JAK inhibitor approved for moderate-to-severe chronic hand dermatitis. This review covers its mechanism, phase 2 and DELTA 1–3 trial results, long-term safety without a boxed warning, and its role as a steroid-sparing option in clinical practice.
FAMILY PRACTICE
Topical Roflumilast Cream for Plaque Psoriasis: Case Presentations to Primary Care
Explore two case studies of plaque psoriasis, treatment challenges, and novel therapeutic options, including topical roflumilast 0.3% cream. Learn how targeting PDE4 can improve psoriasis management, offering a non-steroidal, effective, and convenient solution for patients with different severities.































